Published Clinical Study Illustrates Benefits of Promentum Recover as Low-Dose Solution for Post Exercise Recovery
MOMENCE, Ill., April 23, 2026 /PRNewswire/ -- A recently published human clinical…
From South America to South India: A Young Life Stands Tall Again After Complex Robotic Spine Surgery
Chennai strengthens its position as a global hub for advanced spine care…
Snail Games USA Releases New Developer Diary for Internally Developed Upcoming AAA Title For The Stars
April 23, 2026 17:05 ET | Source: Snail, Inc. CULVER CITY, Calif.,…
Parker Increases Quarterly Cash Dividend 11% to $2.00 per Share
April 23, 2026 17:00 ET | Source: Parker-Hannifin Corporation CLEVELAND, April 23,…
SonaBuds Analyzed: Why Is SonaBuds AI Translator Earbud Trending In The United States?
New York City, NY, April 23, 2026 (GLOBE NEWSWIRE) -- There is…
Brandwatch Expands APAC Data Coverage to Strengthen Global Insight for Marketers
New access to key APAC platforms helps global enterprises understand fragmented global audiences and…
Inside the World of UCEED Rankers Experiencing Design in Action
AHMEDABAD, India, April 22, 2026 /PRNewswire/ -- For most of India's brightest design…
/C O R R E C T I O N — Smashify/
In the news release, SMASHIFY LAUNCHES BETA PLATFORM TO REWRITE THE STREAMING…
IMAAVY (nipocalimab)shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)
Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions…
